Skip to main content

Department

Toxicology

Preferred Sample Type

Etizolam

Suitable Specimen Types

  • Serum
  • EDTA Plasma
  • Li Hep Plasma
50 ul of plasma or serum.

Specimen Transport

Usual

Sample Processing in Laboratory

Centrifuge and place in toxicology box in cold room.

Sample Preparation

Centrifuge

Turnaround Time

3 working days

Sample Stability

4 ºC

Etizolam

General Information

Etizolam (Depas) is a thienotriazolodiazepine derivative, similar in structure to brotizolam, that has been in clinical use in certain Asian and European countries since 1983 as a sedative-hypnotic drug. It has gathered some popularity on the new psychoactive substance (NPS) market in the UK and Europe. Etizolam is unlicensed in the UK although used as a prescribed medication in other countries such as India, Italy and Japan. A 1 mg tablet is equivalent to a 10 mg diazepam (Valium) tablet.

The adverse effects of etizolam therapy include confusion, disorientation, ataxia, slurred speech and delerium.

 

Patient Preparation

None required.

Notes

Measured by LC-MS/MS

Reference Range

Please contact laboratory for interpretation.

Specifications

  • EQA Scheme?: No